IBO ▲ +4.3% - Impact BioMedical Inc. $IBO - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) Impact Biomedical announced a 1-for-12.62 reverse stock split as it moves toward completing its merger with Zoar Limited. The reverse split is a common mechanism used to consolidate shares ahead of a major corporate transaction, and the progress toward merger completion drove the stock up 4.3% today. 14-SEP-2026 09:26 PM ET